(PLRX) – Hot Comments
-
Piper Sandler highlights 12 biotech takeover targets as M&A 'about as conducive as we've seen'
-
Baird Starts Pliant Therapeutics (PLRX) at Outperform, 'We believe there's currently little priced in the stock'
-
-
-
-
Back to PLRX Stock Lookup